64 phenotypes from 6 alleles in 15 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Dbn1em1(IMPC)Bay/Dbn1em1(IMPC)Bay C57BL/6N-Dbn1em1(IMPC)Bay/Bay	abnormal coat appearance	J:211773
	abnormal eye anterior chamber depth	J:211773
	hyperactivity	J:211773
	increased cornea thickness	J:211773
Dbn1em2(IMPC)Mbp/Dbn1em2(IMPC)Mbp C57BL/6N-Dbn1em2(IMPC)Mbp/Ucd	abnormal allantois morphology	J:211773
	abnormal chorioallantoic fusion	J:211773
	abnormal embryo turning	J:211773
Dbn1tm1.1Lbc/Dbn1+ B6.Cg-Dbn1tm1.1Lbc	abnormal dendritic spine morphology	J:224553
Dbn1tm1.1Lbc/Dbn1tm1.1Lbc B6.Cg-Dbn1tm1.1Lbc	abnormal dendritic spine morphology	J:224553
	abnormal hippocampus morphology	J:224553
	impaired synaptic plasticity	J:224553
Dbn1tm1.1Shira/Dbn1tm1.1Shira either: C57BL/6-Dbn1tm1.1Shira or (involves: C57BL/6CrSlc * C57BL/6J * FVB/N)	impaired cued conditioning behavior	J:158208
Dbn1tm1a(KOMP)Wtsi/Dbn1+ C57BL/6N-Dbn1tm1a(KOMP)Wtsi/Wtsi	increased leukocyte cell number	J:211773
Dbn1tm1a(KOMP)Wtsi/Dbn1tm1a(KOMP)Wtsi C57BL/6N-Dbn1tm1a(KOMP)Wtsi/Wtsi	decreased body weight	J:175295
	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating calcium level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating fructosamine level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased circulating serum albumin level	J:175295
	decreased circulating total protein level	J:175295
	decreased mean corpuscular volume	J:175295
	decreased total body fat amount	J:175295
	increased circulating chloride level	J:175295
	preweaning lethality, incomplete penetrance	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+ C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Bay	decreased circulating cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased vertical activity	J:211773
	enlarged heart	J:211773
	unresponsive to tactile stimuli	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+ C57BL/6N-Dbn1tm1b(KOMP)Wtsi/H	abnormal vertebrae morphology	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+ C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Ics	decreased grip strength	J:211773
	decreased total retina thickness	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+ C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Ieg	decreased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+ C57BL/6N-Dbn1tm1b(KOMP)Wtsi/J	decreased circulating free fatty acids level	J:211773
	decreased circulating serum albumin level	J:211773
	increased lean body mass	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+ C57BL/6N-Dbn1tm1b(KOMP)Wtsi/MbpMmucd	decreased total body fat amount	J:211773
	increased bone mineral content	J:211773
	increased prepulse inhibition	J:211773
	microcephaly	J:211773
	syndactyly	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+ C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Rbrc	increased circulating alkaline phosphatase level	J:211773
	increased exploration in new environment	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+ C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Ucd	decreased total body fat amount	J:211773
	increased bone mineral content	J:211773
	increased circulating phosphate level	J:211773
	increased lean body mass	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+ C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Wtsi	increased CD8-positive, alpha-beta T cell number	J:211773
	increased circulating chloride level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating magnesium level	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+ C57BL/6NCrl-Dbn1tm1b(KOMP)Wtsi/Wtsi	abnormal heart morphology	J:211773
	abnormal liver morphology	J:211773
	enlarged heart	J:211773
	increased fasting circulating glucose level	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1tm1b(KOMP)Wtsi C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Bay	abnormal embryo size	J:211773
	preweaning lethality, incomplete penetrance	J:211773
	unresponsive to tactile stimuli	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1tm1b(KOMP)Wtsi C57BL/6N-Dbn1tm1b(KOMP)Wtsi/H	preweaning lethality, incomplete penetrance	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1tm1b(KOMP)Wtsi C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Ics	preweaning lethality, complete penetrance	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1tm1b(KOMP)Wtsi C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Ieg	preweaning lethality, complete penetrance	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1tm1b(KOMP)Wtsi C57BL/6N-Dbn1tm1b(KOMP)Wtsi/J	preweaning lethality, incomplete penetrance	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1tm1b(KOMP)Wtsi C57BL/6N-Dbn1tm1b(KOMP)Wtsi/MbpMmucd	microcephaly	J:211773
	preweaning lethality, complete penetrance	J:211773
	preweaning lethality, incomplete penetrance	J:211773
	syndactyly	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1tm1b(KOMP)Wtsi C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Rbrc	preweaning lethality, complete penetrance	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1tm1b(KOMP)Wtsi C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Ucd	preweaning lethality, complete penetrance	J:211773
	preweaning lethality, incomplete penetrance	J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1tm1b(KOMP)Wtsi C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Wtsi	abnormal brachial plexus formation	J:239583
	abnormal brain internal capsule morphology	J:239583
	abnormal brain white matter morphology	J:239583
	abnormal cervical rib	J:239583
	abnormal forebrain morphology	J:239583
	abnormal hypoglossal canal morphology	J:239583
	abnormal telencephalon morphology	J:239583
	abnormal Wolffian duct connection	J:239583
	absent hypoglossal canal	J:239583
	absent hypoglossal nerve	J:239583
	dilated liver sinusoidal space	J:239583
	preweaning lethality, incomplete penetrance	J:211773
	thin hypoglossal nerve	J:239583
Dbn1tm1b(KOMP)Wtsi/Dbn1tm1b(KOMP)Wtsi C57BL/6NCrl-Dbn1tm1b(KOMP)Wtsi/Wtsi	no spontaneous movement	J:211773
	preweaning lethality, complete penetrance	J:211773